Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants ; volume:18 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-10 ; date:12.2018
BMC cardiovascular disorders ; 18, Heft 1 (27.4.2018), 1-10, 12.2018
- Creator
-
Brinkmeier-Theofanopoulou, Maria
- Contributor
-
Tzamalis, Panagiotis
Wehrkamp-Richter, Susan
Radzewitz, Andrea
Merkel, Matthias
Schymik, Gerhard
van Mark, Gesine
Bramlage, Peter
Schmitt, Claus
Luik, Armin
SpringerLink (Online service)
- DOI
-
10.1186/s12872-018-0804-6
- URN
-
urn:nbn:de:101:1-2018070115314164025087
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brinkmeier-Theofanopoulou, Maria
- Tzamalis, Panagiotis
- Wehrkamp-Richter, Susan
- Radzewitz, Andrea
- Merkel, Matthias
- Schymik, Gerhard
- van Mark, Gesine
- Bramlage, Peter
- Schmitt, Claus
- Luik, Armin
- SpringerLink (Online service)
Other Objects (12)
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
Target-specific oral anticoagulants - new approaches in the field of oral anticoagulation
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases
Anticoagulation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
Target-specific oral anticoagulants - new approaches in the field of oral anticoagulation
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases
Anticoagulation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
Target-specific oral anticoagulants - new approaches in the field of oral anticoagulation
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa
Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
COVID-19 Outbreak Impact on Anticoagulants Utilization: An Interrupted Time-Series Analysis Using Health Care Administrative Databases
Anticoagulation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation